1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 KEY DELIVERABLES OF THE STUDY
1.3 BASE CURRENCY, BASE YEAR, AND FORECAST PERIOD
1.4 GENERAL STUDY ASSUMPTIONS

2 RESEARCH APPROACH AND METHODOLOGY
2.1 INTRODUCTION
2.1.1 SIZE ESTIMATION
2.1.2 FORECASTING METHODOLOGY
2.2 RESEARCH PHASES
2.2.1 Secondary research
2.2.2 Primary research
2.2.3 Econometric modelling
2.2.4 Expert validation
2.3 ANALYSIS DESIGN
2.4 STUDY TIMELINE

3 OVERVIEW
3.1 EXECUTIVE SUMMARY
3.2 KEY INFERENCES

4 MARKET DYNAMICS
4.1 DRIVERS
4.1.1 Rising demand for fast and self-contained test
4.1.2 Technological Advancements
4.1.3 Miscellaneous
4.2 RESTRAINTS
4.2.1 Product recalls due to false advertising & inaccurate results
4.2.2 Wrong results (false positives) due to some specific medications
4.2.3 Variable per capita spending in EU countries
4.3 OPPORTUNITIES
4.3.1 Data storage and ease in access
4.3.2 Cultural Strategy
4.4 CHALLENGES
4.4.1 Complexity of the Supply Chain Throughout the EU
4.4.2 Lack of Maternal Healthcare Facilities in Europe

5 MARKET SEGMENTATION
5.1 INTRODUCTION
5.2 EUROPE PREGNANCY AND FERTILITY TESTING MARKET, BY PRODUCT TYPE
5.2.1 Europe Pregnancy and Fertility Testing Market, By Product Type, Pregnancy Test Kits
5.2.2 Europe Pregnancy and Fertility Testing Market, By Product Type, Fertility/Ovulation Test Kits
5.3 EUROPE PREGNANCY AND FERTILITY TESTING MARKET, BY TEST TYPE
5.4 EUROPE PREGNANCY AND FERTILITY TESTING MARKET, BY END USER

6 GEOGRAPHICAL ANALYSIS
6.1 EUROPE PREGNANCY AND FERTILITY TESTING MARKET, BY COUNTRY
6.1.1 United Kingdom (U.K.) Pregnancy and Fertility Testing
6.1.2 Germany Pregnancy and Fertility Tesing
6.1.3 France Pregnancy and Fertility Testing
6.1.4 Spain Pregnancy and Fertility Testing
6.1.5 Italy Pregnancy and Fertility Testing
6.1.6 Rest of Europe Pregnancy and Fertility Testing

7 STRATEGIC ANALYSES
7.1 PEST ANALYSIS
7.1.1 Political
7.1.2 Economical
7.1.3 Social
7.1.4 Technological
7.2 PORTER’S FIVE FORCE ANALYSIS
7.2.1 Threat of New Entrants
7.2.2 Threat of Substitutes
7.2.3 Bargaining Power of Buyers
7.2.4 Bargaining Power of Suppliers
7.2.5 Competitive Rivalry

8 MARKET LEADER ANALYSIS
8.1 ALERE INC.
8.1.1 Overview
8.1.2 Financials (in USD Million)
8.1.3 Product Analysis
8.1.4 Recent Developments
8.1.5 SWOT Analysis
8.1.6 Analyst Overview
8.2 BIOMERIEUX
8.2.1 Overview
8.2.2 Financials (in USD Million)
8.2.3 Product Analysis
8.2.4 Recent Developments
8.2.5 SWOT Analysis
8.2.6 Analyst Overview
8.3 EFK DIAGNOSTICS
8.3.1 Overview
8.3.2 Financials (in USD Million)
8.3.3 Product Analysis
8.3.4 Recent Developments
8.3.5 SWOT Analysis
8.3.6 Analyst Overview
8.4 QUIDEL CORPORATION
8.4.1 Overview
8.4.2 Financials (in USD Million)
8.4.3 Product Analysis
8.4.4 Recent Developments
8.4.5 SWOT Analysis
8.4.6 Analyst Overview
8.5 PRESTIGE BRANDS INC.
8.5.1 Overview
8.5.2 Financials (in USD Million)
8.5.3 Product Analysis
8.5.4 Recent Developments
8.5.5 SWOT Analysis
8.5.6 Analyst Overview
8.6 SWISS PRECISION DIAGNOSTICS GMBH (SPD)
8.6.1 Overview
8.6.2 Product Analysis
8.6.3 Analyst Overview
8.7 GERATHERM MEDICAL AG
8.7.1 Overview
8.7.2 Product Analysis
8.7.3 Analyst Overview
8.8 EMSIG
8.8.1 Overview
8.8.2 Product Analysis
8.8.3 Analyst Overview
8.9 BIO ALETRNATIVE MEDICAL DEVICES (BIO-AMD)
8.9.1 Overview
8.9.2 Product Analysis
8.9.3 Analyst Overview
8.1 DUTCH DIAGNOSTICS
8.10.1 Overview
8.10.2 Product Analysis
8.10.3 Analyst Overview

9 COMPETITIVE LANDSCAPE
9.1 COMPARATIVE ANALYSIS
9.2 MERGERS & ACQUISITIONS
9.3 COLLABORATIONS, AGREEMENTS & EXPANSIONS

10 MARKET OUTLOOK